Correlation between defined clinical parameters and patients with or without proven/probable IA after alloSCT
| Clinical parameters . | Patients with proven/probable IA, % . | Controls, % . | P . | Odds ratio . |
|---|---|---|---|---|
| Corticosteroid therapy | .971 | 0.98 [0.29-3.19] | ||
| Less than 2 mg/kg | 58.0 | 57.4 | ||
| More than 2 mg/kg | 42.0 | 42.6 | ||
| Acute GVHD | .161 | 2.11 [0.63-7.11] | ||
| Grade 0 to 1 | 52.6 | 70.4 | ||
| Grade 2 to 4 | 47.4 | 29.6 | ||
| Chronic GVHD | .367 | 2.31 [0.31-15.32] | ||
| None | 84.2 | 92.6 | ||
| Limited/extensive | 15.8 | 7.4 | ||
| CD34 selection | .144 | 0.24 [0.02-2.40] | ||
| Yes | 93.5 | 76.9 | ||
| No | 6.5 | 23.1 | ||
| RSV infection | .004* | 6.05* [1.65-23.68] | ||
| Yes | 52.6 | 15.1 | ||
| No | 47.4 | 84.9 | ||
| CMV infection | .112 | 2.25 [0.72-7.14] | ||
| Yes | 45.8 | 27.1 | ||
| No | 54.2 | 72.9 |
| Clinical parameters . | Patients with proven/probable IA, % . | Controls, % . | P . | Odds ratio . |
|---|---|---|---|---|
| Corticosteroid therapy | .971 | 0.98 [0.29-3.19] | ||
| Less than 2 mg/kg | 58.0 | 57.4 | ||
| More than 2 mg/kg | 42.0 | 42.6 | ||
| Acute GVHD | .161 | 2.11 [0.63-7.11] | ||
| Grade 0 to 1 | 52.6 | 70.4 | ||
| Grade 2 to 4 | 47.4 | 29.6 | ||
| Chronic GVHD | .367 | 2.31 [0.31-15.32] | ||
| None | 84.2 | 92.6 | ||
| Limited/extensive | 15.8 | 7.4 | ||
| CD34 selection | .144 | 0.24 [0.02-2.40] | ||
| Yes | 93.5 | 76.9 | ||
| No | 6.5 | 23.1 | ||
| RSV infection | .004* | 6.05* [1.65-23.68] | ||
| Yes | 52.6 | 15.1 | ||
| No | 47.4 | 84.9 | ||
| CMV infection | .112 | 2.25 [0.72-7.14] | ||
| Yes | 45.8 | 27.1 | ||
| No | 54.2 | 72.9 |
indicates significant P value (<.01) and odds ratio.